Sun Pharma launches dry eye treatment with NCELL tech in Canada

CEQUA’s NCELL technology improves the bioavailability and physicochemical stability of cyclosporine to increase ocular tissue penetration

Related Keywords

United States ,Canada ,Ottawa ,Ontario ,America ,Canadians ,Sun Pharma ,W Bruce Jackson ,Abhay Gandhi ,Sun Pharmaceutical Industries ,Mcgill University ,Department Of Ophthalmology ,University Of Ottawa ,Sun Pharma Canada ,North America ,Dry Eye ,Sequa ,Cell ,